North America Intrauterine Contraceptive Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Intrauterine Contraceptive Devices Market Segmentation, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2032

Intrauterine Contraceptive Devices Market Size

• The North America Intrauterine Contraceptive Devices Market was valued at USD 1.1 Billion in 2024 and is expected to reach USD 2.2 Billion by 2032
• Drivers of the North America Intrauterine Contraceptive Devices Market include include the rising awareness of family planning and reproductive health options among women, the increasing preference for long-acting reversible contraceptives (LARCs) due to their convenience and effectiveness, and supportive government initiatives aimed at improving access to contraceptive methods. Additionally, ongoing advancements in IUD technology, such as the development of hormone-releasing devices, contribute to market growth.

North America Intrauterine Contraceptive Devices Market Analysis

• The North America Intrauterine Contraceptive Devices (IUD) Market is characterized by an increasing adoption of IUDs as a popular form of long-acting reversible contraception. This market encompasses both hormonal and non-hormonal IUD options, catering to a diverse range of women's reproductive health needs.
• The market is driven by a growing awareness of reproductive health and family planning, alongside changing societal attitudes towards contraception. Women's preferences for long-lasting and effective contraceptive methods, such as IUDs, have contributed to their rising popularity in the region.
• Regulatory support from health authorities, along with ongoing innovations in IUD technology, such as improved designs, comfort, and efficacy, are bolstering market growth. Recent developments include the introduction of IUDs with extended duration of action and lesser side effects, improving user experience.

Report Scope and Intrauterine Contraceptive Devices Market Segmentation         

Intrauterine Contraceptive Devices Market Trends

“increased adoption of long-acting reversible contraceptives (LARCs)”

• IUDs offer over 99% effectiveness and require minimal user intervention, making them a preferred choice for women seeking reliable, long-term contraception
• Between 2015 and 2019, the use of LARCs among U.S. teens aged 15–19 tripled, indicating a shift towards more effective birth control methods in this demographic

Intrauterine Contraceptive Devices Market Dynamics

Driver

“rising global incidence of unintended pregnancies”

• According to the WHO, nearly 121 million unintended pregnancies occur annually worldwide, pushing demand for more reliable, long-term contraceptive solutions like IUDs.
• IUDs offer up to 10 years of protection and are more affordable over time compared to short-term methods, making them a practical solution for preventing unplanned pregnancies.
• Public health organizations and governments are increasingly promoting IUDs through subsidies and awareness programs to combat rising fertility rates and improve maternal health outcomes.

Opportunity

“development and adoption of eco-friendly IUDs”

• Sustainable Materials: Manufacturers are exploring biodegradable polymers and plant-based materials to create IUDs that are more environmentally friendly, aligning with global sustainability trends.
• There is a growing consumer preference for products that are both effective and environmentally conscious, which can drive market differentiation and brand loyalty.

Restraint/Challenge

“risk of side effects and complications associated with IUD use”

• IUDs can cause pain, cramping, irregular bleeding, and in rare cases, uterine perforation or infections, which can deter potential users and raise safety concerns.
• Historical controversies and misinformation about IUDs—such as the Dalkon Shield case in the 1970s—still impact public trust in these devices, especially in certain regions.

Intrauterine Contraceptive Devices Market Scope

The market is segmented on the basis of type, end user, and distribution channel.

Intrauterine Contraceptive Devices Market Analysis

“U.S. is the Dominant Country in the Intrauterine Contraceptive Devices Market”

• The country boasts a well-established healthcare system with widespread access to reproductive health services. High levels of awareness about contraceptive options, including IUDs, contribute to informed decision-making among women. This infrastructure supports the adoption of effective and long-term contraceptive methods like IUDs.
• Government programs such as Title X and the Affordable Care Act (ACA) in the United States mandate insurance coverage for contraceptive methods, including IUDs. These policies have significantly improved access to and affordability of IUDs, particularly among underserved populations.

“U.S. is Projected to Register the Highest Growth Rate in the Intrauterine Contraceptive Devices Market”

• The U.S. is seeing a significant shift towards long-acting reversible contraceptives (LARCs) like intrauterine devices (IUDs). This trend is supported by healthcare professionals advocating for IUDs due to their high efficacy and low-maintenance requirements compared to traditional contraceptive methods.
• Enhanced awareness campaigns and educational programs about reproductive health are empowering women to make informed choices about their contraceptive options. Health initiatives that highlight the benefits and safety of IUDs have contributed to their growing acceptance among U.S. women.

Intrauterine Contraceptive Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• AbbVie Inc. (Allergan)
• Bayer AG
• The Cooper Companies, Inc.
• DKT International
• EUROGINE S.L.
• Pregna International Limited
• Prosan International BV
• SMB Corporation of India
• Melbea AG
• OCON Medical Ltd.
• Mylan N.V. (Viatris)
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• HLL Lifecare Limited

SKU-1162